10:18 AM EST - Medicenna Therapeutics Corp. : Received a notice from the NASDAQ Stock Market LLC granting the Company’s request for a 180-day extension to regain compliance with the minimum bid price requirement of US$1.00 per share under the Nasdaq Listing Rule 5450(a)(1). The Company was first notified by NASDAQ of its failure to comply with the Minimum Bid Requirement on October 25, 2022, and was given until April 24, 2023 to regain compliance. The Company now has until October 23, 2023 to meet the requirement. Medicenna Therapeutics Corp.
shares T.MDNA are trading down $0.04 at $0.91.
